MDM-2 is one of the target genes of the p53 tumor suppressor protein. Its best characterized function is found in the inhibition of p53's ability to modulate transcription. Deregulated expression of MDM-2 could thus at least partially substitute for p53 mutation in the process of tumorigenesis. We show here that MDM-2 is highly expressed in biopsies of normal human skin or in vitro reconstituted human skin. The protein is detected in the nucleus of keratinocytes throughout the dierent layers of the epidermis and in reconstituted skin as early as the two to three cell layer stage. The 90 kiloDalton (kD) protein is one of the major forms detected in Western blot experiments. MDM-2 is detected in skin reconstituted from keratinocytes in which p53 is inactivated by mutation or degradation by E6 protein, providing evidence that MDM-2 expression in the skin can occur in the absence of wild type p53. Moreover, we found no correlation between the p53 status and MDM-2 expression levels in a series of basal and squamous cell carcinomas or Bowen diseases. Our data provide ®rst evidence for the expression of MDM-2 in a dierentiated adult tissue.
Originally discovered as a gene ampli®ed in the spontaneously transformed 3T3DM cell line, MDM-2 was subsequently found to encode a 90 kD protein interacting with p53 tumor suppressor protein (CahillySnyder et al., 1987; Momand et al., 1992; Barak and Oren, 1992) . Binding of p90 to p53 leads to inhibition of the transcription modulation ability of p53: this could contribute to the oncogenic properties of MDM-2 by interfering with the activation of growth suppressive genes by p53 (Momand et al., 1992; Oliner et al., 1993; Finlay, 1993; Chen et al., 1995) . Alternatively, the ability of p53 to induce cell death may be aected (Haupt et al., 1996; Chen et al., 1996) . Indeed, the gene was found to be ampli®ed or overexpressed in several tumors, most of them containing wild type p53 (e.g. Leach et al., 1993; Waber et al., 1993; Watanabe et al., 1994) . MDM-2 is one of the target genes of p53: a p53 responsive element was localized in the ®rst intron of the gene, controlling one of the two MDM-2 promoters (Wu et al., 1993; Barak et al., 1993; Zauberman et al., 1995) . The existence of a negative feedback loop was therefore proposed: inhibition of p53 activity by MDM-2 would allow the cell to resume proliferation under the appropriate circumstances, for instance after repair of damaged DNA caused by X-ray or u.v.-irradiation Perry et al., 1993) . The phenotypes of knock-out mice provided further evidence in favour of the functionality of the MDM-2-P53 feedback loop. Null mice for MDM-2 were not viable beyond the implantation stage, however, viability was recovered by the additional knock-out of the p53 alleles (Montes de Oca Luna et al., 1995; Jones et al., 1995) . These results also pointed to a more general role for the feedback loop during development. Such a role would be fully compatible with the activation of both p53 and MDM-2 during a normal cell cycle (Reich and Levine, 1984; Olson et al., 1993) .
There are several indications that inhibition of p53 activity is not the unique function of MDM-2. Indeed, several lower molecular weight forms of the protein are detected which do not interact with p53. This could be due to the use of internal start codons, dierential splicing and/or alternative promoters Haines et al., 1994; Barak et al., 1994) . Recently, MDM-2 was shown to stimulate E2F-1/DP1 activity by direct interaction (Martin et al., 1995) . Results from another group suggest an interference with pRb activity (Xiao et al., 1995) . Both mechanisms would contribute to the stimulation of the passage from G 1 to S in the cell cycle. An additional interaction of MDM-2 with L5 ribosomal protein has also been demonstrated, opening the perspective of a role in translational control . Also, a few tumors were described in which both MDM-2 overexpression and p53 mutations were detected and which were characterized by a worse prognosis (CordonCardo et al., 1994) . Finally, MDM-2 can transform cells in the absence of p53 (Dubs-Poterzman et al., 1995) .
In order to better understand the role of MDM-2 in normal physiology and in oncogenesis we analysed its expression in normal and pathological skin. Skin is particularly appropriate for this type of analysis. Several dierentiation stages, from proliferating stem cells to terminally dierentiated squamous cells, can be analysed in single tissue sections. This dierentiation can be fully reproduced and manipulated in vitro. In addition, the role of p53 dysfunctions in dierent types of skin cancers or pathologies has been extensively studied, and a direct role for u.v. irradiation and p53 mutation in the etiology of some skin cancers is strongly suspected (Brash et al., 1991; MoleÁ s et al., 1993; Ziegler et al., 1994) .
MDM-2 protein is detected throughout normal human skin by immuno¯uorescence staining
Tissue sections from normal human skin (NHS) were analysed by indirect immuno¯uorescence labeling of the MDM-2 protein by the 2A10 monoclonal antibody (Figure 1 ) or a polyclonal antibody (not shown). A strong nuclear staining was detected throughout the epidermis, yet was absent in control experiments.
Since p53 activates the expression of the MDM-2 gene, we looked for p53 expression in NHS using dierent antibodies as tools. Nuclear p53 expression was not reported to be detectable in NHS in the absence of u.v. irradiation (Hall et al., 1993) : indeed, we failed to detect the presence of p53 protein in the nucleus with a panel of monoclonal antibodies i.e. DO7, 1801, 421, 240 or with the CM1 polyclonal antibody (results not shown). As reported by Spandau (1994) a cytoplasmic staining was observed with the 421 antibody in basal layers of the epidermis, however, we could not reproduce the staining with the 240 antibody. Nuclear staining of mutant p53 expressing HaCaT cells was used as positive control in each case. Low levels of p53 protein were detected in Western blot experiments on normal epidermal extracts (not shown). Thus, MDM-2 protein is expressed in an adult tissue in which most of the cells are de®nitively withdrawn from the cell cycle, in the absence of any detectable nuclear p53 expression.
The p90 form of MDM-2 is present in epidermal extracts
It was proposed that full length p90 is translated predominantly from mRNAs initiated at the p53-dependent promoter, while shorter proteins are translated from transcripts initiated at the constitutive promoter (Barak et al., 1994) . In view of the absence of any detectable p53 in the nucleus, it was of interest to verify the presence of p90 in adult skin. To this end, we performed a Western blot experiment on protein extracts of NHS. As shown in Figure 2A , with the 2A10 monoclonal we detected a strong band of approximately 90 kD which comigrated with the major protein form present in 3T3DM cells, used as control. This protein was also detected using the 3G5 monoclonal antibody recognizing the N-terminal part of the protein which is necessary for binding to p53 . Other bands were detected with the two antibodies, i.e. a 165 kD, a 115 kD and a 38 kD band. The large smear between 48 and 75 kD, which was also detected with control antibodies, is most probably due to non-speci®c recognition of the cytokeratins present in the epidermal extracts. In skin reconstructed from primary keratinocytes (NHEK), p90 was clearly the major protein form ( Figure 2B , see below). The nature of the other bands is currently under investigation.
MDM-2 mRNA is detected in normal human skin by in situ hybridization
In order to verify if the increased levels of MDM-2 protein in NHS could be explained, at least in part, by increased mRNA levels, we performed in situ hybridization experiments. Using a human anti-sense RNA probe, we detected a strong signal in the epidermis, with higher intensity in basal layers ( Figure 3 ). This signal was absent when the sense RNA was used as a probe. These results suggest that MDM-2 expression in NHS is due to increased transcription of the gene, however, protein stabilization or increased translation could contribute to the continuing high levels of expression in super®cial layers.
Expression of MDM-2 during skin dierentiation in vitro
In vitro reconstitution experiments allow to follow the dierent steps of skin development, from proliferating monolayers of keratinocytes to a fully dierentiated multilayered epidermis. Within 15 days of culture, an epidermis with similar morphology to that observed in vivo was reconstituted. It was thus particularly interesting to follow MDM-2 expression during dierent steps of skin reconstitution kinetics by immuno¯uorescence labeling using the 2A10 monoclonal antibody (Figure 4) . Importantly, no MDM-2 protein was detected in the nuclei of keratinocytes in monolayers. In contrast, a predominantly perinuclear staining was detected at this stage ( Figure 4A ). Detectable nuclear levels of the protein appeared at the two to three cell layers stage ( Figure 4B ), which suggests that the appearance of MDM-2 in the nucleus is part of the normal dierentiation program of the epidermis. Again, high levels of the protein are Normal human adult skin (NHS) samples were obtained from healthy volunteers undergoing plastic surgery (n=16) after informed consent. The ratio between sunexposed and non sun-exposed skin sites was 0.4. Immediately after removal, NHS samples were embedded in OCT-compound (Miles Scienti®c, Paris, France) to perform tissue sections, snap frozen in liquid nitrogen and then stored at 7808C until use. IF studies were carried out on 6 mm thick cryostat tissue-sections, which were ®xed and permeabilized in methanol for 10 min at room temperature (RT), then washed three times 5 min in phosphate buered saline (PBS) and two times 5 min in PBS with 0.5% bovine serum albumin (BSA). The tissue sections were incubated with anti-MDM2 mAb 2A10 for 1 h at 378C in a humid chamber and then washed three times for 5 min each in PBS-BSA 0.5%. After that, sections were incubated with a goat biotinylated anti-mouse IgG (Sigma Chemical Company, St Louis, USA) for 1 additional h and washed three times as before. The sample was then incubated with streptavidin texas red (Amersham, UK) and rinsed three times in PBS maintained throughout fully dierentiated reconstituted skin ( Figure 4C ). The major form of MDM-2 detected with the 2A10 monoclonal is p90 ( Figure 2B ). p53 protein was also detected in Western blot experiments (not shown).
MDM-2 expression is independent of wild type p53 in pathological keratinocytes
To verify if wild type (wt) p53 was required for MDM-2 expression in human skin, we analysed reconstituted skin from HaCaT cells, which carry p53 mutations on both alleles (Lehman et al., 1993) . A clear nuclear staining for MDM-2 was detected throughout the reconstituted tissue ( Figure 5A ). A similar observation was done with reconstituted tissue from A431 cells, which carry a mutation on one allele of p53 and showed no transcriptional activity in p53 speci®c reporter tests (Reiss et al., 1992; Park et al., . Hybridoma culture supernatants were used in the experiments. The epidermal sheet from samples of NHS or reconstituted skin (RS) were removed by heating at 568C for 10 min in 0.1 M Tris-HCl, pH 7.0, 1 mM EDTA and 1 mM PMSF. After removal, the epidermis was immediately extracted and denatured in sample buer (2% sodium-dodecyl-sulfate, 20% glycerol, 70 mM DTT, 60 mM Tris pH 6.8 and 0.001% bromophenol blue), vortexed and centrifuged at 15 000 g for 15 min. The supernatant was used for PAGE electrophoresis. 3T3DM cells were pelleted and quick-frozen three times. Cells were incubated 30 min on ice in lysis buer (15 mM KH 2 PO 4 pH 7.8, 8 mM MgCl 2 , 0.05% Triton X-100, 1 mM DTT, 0.2 mM PMSF, 1 mg/ml Aprotinin, 1 mg/ml Leupeptin). These dierent protein extracts were resolved by sodium dodecyl sulfate 7.5% polyacrylamide gel electrophoresis (SDS ± PAGE) along with molecular weight markers and were electrically transferred to a Hybond-C membrane (Amersham, UK) in a 20% methanol buer. The blot was probed with MDM2-mAbs (2A10, 3G5) and detected with horseradish peroxidase and enhanced chemiluminescence (ECL, Amersham) following suppliers protocol S-UTP (800 Ci/mmol)-labeled speci®c anti-sense or sense RNA probe obtained after in vitro transcription of a cDNA pBluescript expression vector (Stratagene), in situ hybridization was performed as previously described (Harper et al., 1986; Theillet et al., 1989) 1994; Figure 5C ). In this case also, p90 was the major form detected in Western blot experiments (see Figure  2B ). Finally, keratinocytes in which E6 protein was coexpressed with E7 protein of HPV16 also expressed MDM-2 after skin reconstruction (Sedman et al., 1992;  Figure 5E ). Thus, MDM2 protein is expressed in tissue reconstructed from human keratinocytes even when endogenous wt p53 protein is mutated or degraded by E6 protein.
We looked also for MDM-2 expression in dierent types of skin tumors. We have analysed seven squamous cell carcinomas (SCC), ten basal cell carcinomas (BCC) and four Bowen diseases, which were previously characterized for their p53 status (MoleÁ s et al., 1993) . In all cases, lower or at most equivalent levels of MDM-2 were detected by indirect immuno¯uorescence analysis. There was no direct link with the p53 status (Table 1 and Figure 6A and B). Thus, we could not make a direct correlation between p53 status and MDM-2 expression in the dierent tumors analysed.
The ®ndings reported in this work tend to reevaluate or at least extend some of the recent hypotheses put forward on the role of MDM-2 in cell physiology. MDM-2 functions as a negative modulator of p53 transcriptional activity, leading to the impairment of p53's role as cell cycle blocker or inducer of apoptosis. Its overexpression in several tumors underlines its positive implication in cellular , 1990) . Brie¯y, keratinocytes and melanocytes were isolated by incubating small skin specimens in trypsin/EDTA overnight. Cells were then plated on Petri dishes and grown in their respective selecting medium. Keratinocytes selective medium included a low calcium (0.09 mM) serum free medium SFM (Gibco BRL, France) supplemented bovine pituitary extract (35 mg/ml), and EGF (5 ng/ ml). Isolated keratinocytes were further characterized by cytokeratin expression. Reconstituted normal human skin (NHS) was obtained according to a technique developed in our laboratory (Basset-SeÂ guin et al., 1990) . Brie¯y, a 4 mm punch biopsy of NHS is deposited on a de-epidermized dermis maintained at the air liquid interface by a metallic suport. Culture medium contained a mixture (3 : 1) of DMEM and Ham F12 in the presence of 10% fetal calf serum, cholera toxin (0.1 nM), hydrocortisone (0.4 mg/ml), EGF (20 ng/ml), insulin (5 mg/ml), antibiotics (1% penicillin/streptomycin 10000 IU) and fungicides (1% fungizone). A fully completed epidermis is obtained between 15 to 21 days of culture. Dierentiation of the neo-epidermis has been shown to be very close to that observed in vivo (Sedman et al., 1992) , A431 cells which carry a p53 mutation on one of the two alleles and HaCaT cells which carry p53 mutations on both alleles. All these cell lines were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) enriched with 10% fetal calf serum. Reconstituted tissues from tumoral cell lines were obtained according to Prunieras' method (Prunieras, 1979) . Cell suspensions (400 000 cells in 10 ml of culture medium) were deposited on a morti®ed de-epidermized dermis and cultured as described above. Reconstituted tissues were collected after 7 to 28 days of culture. All specimens were embedded in OCT compound, frozen in liquid nitrogen and stored at 7808C until use proliferation. More surprising are our results which clearly show a high level of MDM-2 expression in dierentiated cells which are de®nitively withdrawn from the cell cycle.
At ®rst sight, the expression of MDM-2 in NHS seems to be incompatible with a role for p53 as tumor suppressor in this tissue. Nevertheless, p53 mutations were detected in a great number of skin tumors. p53 is induced in human skin after mild exposure to sunlight, and could exert its protective function by inducing premature cell death of keratinocytes, the so-called sunburn cells (Hall et al., 1993; Ziegler et al., 1994) . Thus, if the main protective function of p53 in NHS is to induce apoptosis of sunburn cells, it is likely that MDM-2 would not be eective in suppressing death of those cells. This could be due to two main reasons. (i) The transcriptional activity of p53 would not be required to induce apoptosis in keratinocytes as was observed for some cell types (reviewed by Bates and Vousden, 1996) . Indeed, inhibition of apoptosis by MDM-2 occurred only in cells which require the transactivation function of p53 for cell death (Haupt et al., 1996; Chen et al., 1996) . (ii) MDM-2 is present in the nucleus only after cell cycle withdrawal, and would thus not interfere with activation of p53 in proliferating keratinocytes which are likely to be the main target of u.v.-induced tumorigenesis. The absence of nuclear staining for MDM-2 in keratinocytes in monolayers is compatible with the latter hypothesis. In this case, MDM-2 expression in dierentiated cells could even protect these cells against p53-induced apoptosis. Alternatively, MDM-2 expression in skin may ful®ll some other functions not directly related to p53, for instance in translational control .
The existence of any role of p53 in tissue dierentiation is controversial, although some evidence has been provided in a few cases (e.g. Almon et al., 1993; Sah et al., 1995; Soddu et al., 1996) . A recent report indicates an increase in p53 activity during dierentiation of mouse keratinocytes, with a concomittant, yet transient, increase in MDM-2 expression (Weinberg et al., 1995) . Distinct conformations of p53 protein were detected at dierent stages of keratinocyte dierentiation (Spandau, 1994) . It is thus not excluded that p53 contributes to MDM-2 expression in NHS. Nevertheless, our skin reconstitution experiments with cell lines in which p53 is inactivated by mutation or degradation suggest that wild type p53 protein is not required for MDM-2 induction in human skin. The lack of correlation between p53 status and MDM-2 expression in the tumors we examined is fully compatible with this statement.
In conclusion, we provide ®rst evidence for the expression of MDM-2 in a dierentiated adult tissue. This expression could provide either a protective role against p53 activation or a function not directly related to p53. Human skin oers a powerful model to further investigate these tissues. 
